UNSPSC 51392213: Tefazoline

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51392213

Definition

This classification denotes an alpha-adrenergic agonist with the molecular formula C14H18N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9738II2CCH, chemically known as 2-(5,6,7,8-tetrahydro-1-naphthyl)methyl)-2-imidazolin but generally known as tefazoline, which bears US NIH Compound Identifier 163309. European Medicines Agency schedules Tefazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10865MIG.

Read the full definition

The term TEFAZOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25, No. 10 1971, List 11). TEFAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tefazoline under HS 29332990 and SITC 51573. As of Q4 2014, TEFAZOLINE remains the US FDA Preferred Term for this commodity. Tefazoline bears US NLM identifiers UMLS ID C2699906 and NCI Concept Code C75044. SMILES: N1C(=NCC1)CC1C2CCCCC2CCC1.

About UNSPSC 51392213

UNSPSC 51392213 Tefazoline, a Commodity code, covers pharmaceutical products and medical supplies that state and local governments procure for emergency response, public health, and community health initiatives. The single recent opportunity in this code—Seminole County, Florida's IFB for naloxone and drug deactivation systems—reveals that state and local buyers are actually purchasing opioid-reversal medications and harm-reduction equipment rather than tefazoline itself, suggesting a mismatch between the code's nominal scope and current purchasing practice. Issuing bodies under this code span county health departments and community health agencies focused on substance-abuse response and overdose prevention.

Seminole County, Florida is the only jurisdiction with a recent solicitation tied to this code. The county posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023. The contract carries a two-year initial term with a one-year renewal option, fixed-fee pricing, and potential FEMA funding. Vendors must comply with drug-free workplace certification, E-Verify requirements, and specific insurance coverages. The code shows minimal recent activity and the single opportunity reflects procurement of naloxone and drug deactivation systems rather than tefazoline, indicating limited or misaligned use of this particular commodity classification in state and local procurement.

Quick answers

What is UNSPSC 51392213?

UNSPSC 51392213 is Tefazoline, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51392213?

UNSPSC 51392213 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51392213

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code